Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis
Open Access
- 2 August 2017
- journal article
- research article
- Published by Springer Nature in Clinical Proteomics
- Vol. 14 (1) , 1-9
Abstract
Hepatocellular carcinoma is an aggressive malignancy with poor prognosis and easy to recur even the tumor is totally removed by surgery. Portal vascular invasion is one of the major factors contributing to tumor recurrence and poor prognosis. However, why hepatocellular carcinoma is easy to grow into vessels is unclear. Surgical specimens from seven hepatocellular carcinoma patients with portal vein thrombosis and seven patients without vascular invasion were utilized to analyze protein expression by proteomic technique. The proteins in the tumors were separated by 2-dimensional electrophoresis. Protein patterns in the gels were recorded as digitalized images. The differences of expression in hepatocellular carcinoma with or without portal vein thrombosis were identified by mass spectrometry. Clinically, the tumors with portal vein thrombosis were larger than those without portal vein thrombosis. The median survival time for the patients with portal vein thrombosis was much shorter [4 (ranged 2.5–47) vs. 53 (ranged 33–85) months, p = 0.002]. By analyzing the protein expression in cancer tissues with or without portal vein thrombosis, the differences of protein expression were mainly metabolic enzymes. Carbonic anhydrase I, betaine–homocysteine S-methyltransferase 1, fumarate hydratase, isovaleryl-CoA dehydrogenase, short-chain specific acyl-CoA dehydrogenase and arginase-1 were all down-regulated in the tumors with portal vein thrombosis. Metabolic enzymes and cytosol carbonic anhydrases were downregulated in hepatocellular carcinoma with portal vein thrombus. The deficiency of metabolic enzymes and cytosol carbonic anhydrases may alter cellular metabolisms and acid–base balance in hepatocellular carcinoma, which may facilitate to invade portal vein.Keywords
Funding Information
- Chang Gung Memorial Hospital, Linkou (CMRPG-381091)
This publication has 43 references indexed in Scilit:
- Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score AnalysisPLOS ONE, 2016
- Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of TreatmentLiver Cancer, 2015
- Hepatocellular carcinomaThe Lancet, 2012
- Deletion of Betaine-Homocysteine S-Methyltransferase in Mice Perturbs Choline and 1-Carbon Metabolism, Resulting in Fatty Liver and Hepatocellular CarcinomasJournal of Biological Chemistry, 2011
- Fumarase tumor suppressor gene and MET oncogene cooperate in upholding transformation and tumorigenesisThe FASEB Journal, 2010
- Profiling the proteome dynamics during the cell cycle of human hepatoma cellsProteomics, 2008
- Genetic mutation profile of isovaleric acidemia patients in TaiwanMolecular Genetics and Metabolism, 2007
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancerBritish Journal of Cancer, 2003
- The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancerCancer Letters, 2002